As the global economy mends, the 2021 growth of Point of Care Infectious Disease Testing will have significant change from previous year. According to our researcher latest study, the global Point of Care Infectious Disease Testing market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Point of Care Infectious Disease Testing market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Point of Care Infectious Disease Testing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Point of Care Infectious Disease Testing market, reaching US$ million by the year 2028. As for the Europe Point of Care Infectious Disease Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Point of Care Infectious Disease Testing players cover Alere, Thermo Fisher Scientific, F. Hoffmann-La Roche, and Siemens Healthineers, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Point of Care Infectious Disease Testing market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

HIV POC

HBV POC

Pneumonia or Streptococcus Associated Infections

Respiratory Syncytial Virus (RSV) POC

HPV POC

Influenza POC

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals

Clinics

Home

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Alere

Thermo Fisher Scientific

F. Hoffmann-La Roche

Siemens Healthineers

BD

Chembio Diagnostics

Trinity Biotech

Cardinal Health

Quest Diagnostics

Bio-Rad Labs

bioMérieux

Sight Diagnostics

Gene POC

Trivitron Healthcare

OJ-Bio

Ortho-Clinical Diagnostics